Mycophenolate mofetil Terminated Phase 4 Trials for Transplantation, Kidney / Transplants and Implants Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00522548Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients
NCT00133172Effect of Rapid Steroid Withdrawal on Subclinical Markers of Rejection
NCT00420472A Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients Switched From EC-MPS.
NCT00596947Prednisone Withdrawal Versus Prednisone Maintenance After Kidney Transplant